BioCentury | Sep 28, 2018
Clinical News

CHMP backs Luxturna, Lilly's migraine mAb, antibiotic Vabomere

...pyelonephritis; complicated intra-abdominal infection (cIAI); and hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP). Vabomere comprises boron-containing...
BioCentury | Sep 21, 2018
Company News

CHMP backs Luxturna, Lilly's migraine mAb, antibiotic Vabomere

...pyelonephritis; complicated intra-abdominal infection (cIAI); and hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP). Vabomere comprises boron-containing...
BioCentury | Mar 27, 2018
Distillery Therapeutics

Cancer

INDICATION: Multiple myeloma (MM) Patient sample and mouse studies suggest inhibiting IL-18 or NLRP1 could help treat MM. In patient samples, high bone marrow plasma levels of IL-18 correlated with poor overall survival. In two...
BioCentury | Mar 16, 2018
Financial News

Energy firm spins out biotech with $40M series A

...led by Artis Ventures. The newco is using TAE Technologies' accelerator-based neutron beam technology for boron...
...Bauer, who also founded international VC firm Newbury Ventures. TAE Technologies Inc., Foothill Ranch, Calif. Sandi Wong boron...
BioCentury | Mar 12, 2018
Financial News

Energy firm spins out biotech with $40M series A

...led by Artis Ventures. The newco is using TAE Technologies' accelerator-based neutron beam technology for boron...
BioCentury | Feb 16, 2018
Strategy

Pfizer’s chemistry machine

...electrophile for the reaction. It also showed the boronic acid and ester nucleophiles were better boron...
BioCentury | Dec 1, 2017
Company News

Melinta acquires Medicines Co.'s infectious disease unit

...IV formulations, respectively (see BioCentury, June 23 ). Vabomere is a combination of vaborbactam, a boron-containing...
BioCentury | Nov 30, 2017
Company News

Melinta acquires Medicines Co.'s infectious disease unit

...formulations, respectively (see BioCentury Extra, June 20) . Vabomere is a combination of vaborbactam, a boron-containing...
BioCentury | Sep 1, 2017
Clinical News

FDA approves cUTI combo Vabomere from MDCO

...Medicines Co. acquired in 2013 (see BioCentury, Dec. 9, 2013 ). Vabomere comprises vaborbactam, a boron-containing...
BioCentury | Aug 30, 2017
Company News

FDA approves cUTI combo from MDCO

...Rempex Pharmaceuticals Inc. , which The Medicines Co. acquired in 2013. Vabomere comprises vaborbactam, a boron-containing...
Items per page:
1 - 10 of 405
BioCentury | Sep 28, 2018
Clinical News

CHMP backs Luxturna, Lilly's migraine mAb, antibiotic Vabomere

...pyelonephritis; complicated intra-abdominal infection (cIAI); and hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP). Vabomere comprises boron-containing...
BioCentury | Sep 21, 2018
Company News

CHMP backs Luxturna, Lilly's migraine mAb, antibiotic Vabomere

...pyelonephritis; complicated intra-abdominal infection (cIAI); and hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP). Vabomere comprises boron-containing...
BioCentury | Mar 27, 2018
Distillery Therapeutics

Cancer

INDICATION: Multiple myeloma (MM) Patient sample and mouse studies suggest inhibiting IL-18 or NLRP1 could help treat MM. In patient samples, high bone marrow plasma levels of IL-18 correlated with poor overall survival. In two...
BioCentury | Mar 16, 2018
Financial News

Energy firm spins out biotech with $40M series A

...led by Artis Ventures. The newco is using TAE Technologies' accelerator-based neutron beam technology for boron...
...Bauer, who also founded international VC firm Newbury Ventures. TAE Technologies Inc., Foothill Ranch, Calif. Sandi Wong boron...
BioCentury | Mar 12, 2018
Financial News

Energy firm spins out biotech with $40M series A

...led by Artis Ventures. The newco is using TAE Technologies' accelerator-based neutron beam technology for boron...
BioCentury | Feb 16, 2018
Strategy

Pfizer’s chemistry machine

...electrophile for the reaction. It also showed the boronic acid and ester nucleophiles were better boron...
BioCentury | Dec 1, 2017
Company News

Melinta acquires Medicines Co.'s infectious disease unit

...IV formulations, respectively (see BioCentury, June 23 ). Vabomere is a combination of vaborbactam, a boron-containing...
BioCentury | Nov 30, 2017
Company News

Melinta acquires Medicines Co.'s infectious disease unit

...formulations, respectively (see BioCentury Extra, June 20) . Vabomere is a combination of vaborbactam, a boron-containing...
BioCentury | Sep 1, 2017
Clinical News

FDA approves cUTI combo Vabomere from MDCO

...Medicines Co. acquired in 2013 (see BioCentury, Dec. 9, 2013 ). Vabomere comprises vaborbactam, a boron-containing...
BioCentury | Aug 30, 2017
Company News

FDA approves cUTI combo from MDCO

...Rempex Pharmaceuticals Inc. , which The Medicines Co. acquired in 2013. Vabomere comprises vaborbactam, a boron-containing...
Items per page:
1 - 10 of 405